Novartis Japan staffers shredded and deleted to cover trial misconduct, panel finds

Save

Novartis' Japanese unit didn't fake clinical data in a head-to-head leukemia drug study, an investigatory panel found. But that doesn't mean the Swiss drugmaker's staff is off the hook in its latest Japanese scandal. According to the panel's report, employees not only broke the rules repeatedly–they also engaged in a cover-up.